![](https://d1htlas1ystcvb.cloudfront.net/securities/2103/309d97863a914f87138967a338d36d9962031c5f.png)
Genomics and Biotechnology UCITS ETF
(GNOG)
£5.76
Previous business day’s close price
‑£9.98 (‑63.38%)
max available period
£5.12
£15.84
04 Nov 21
01 Jul 24
Details
This ETF tracks the performance of companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.
Ticker: GNOG
ISIN: IE00BM8R0N95
Ticker: GNOG
ISIN: IE00BM8R0N95
Key information
ETF Breakdown
![](https://d1htlas1ystcvb.cloudfront.net/organisations/9925/d98fae74b734bde6830765d75a74843d0d8b4237.png)
Avidity Biosciences Inc
5.3%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1787/c5d37b6bb83437f6bc61b7c1a3235ccab041adba.png)
Moderna Inc
4.9%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7455/7dcbd8aa600283596db78caaa7d727326ec4f267.png)
Natera Inc
4.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/2107/c09712402c56e0d1206fac9492b3a5298f77a59d.png)
Bio‑Techne Corp
4.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7947/596d77d504e4a31761abd898b20e1730b43d72b5.png)
Intellia Therapeutics Inc
4.5%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/10845/a3135de14a1d8790d363135b4e9a9bc5243ab16c.png)
CRISPR Therapeutics AG
4.4%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/2045/d21ee98746c8bbd7a7e6e738c2671d2cf500dd66.png)
Alnylam Pharmaceuticals Inc
4.3%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7463/5fdecd1f324fc83ff044da76a87cb73c509d70c8.png)
Arrowhead Pharmaceuticals Inc.
4.2%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/2665/d64c1b78f0c08661fcc6114c3db12a22c591f01e.png)
BioNTech SE
4.0%
Qiagen N.V.
3.9%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/6765/d161b73cab30c24a1ea4c3f0c2819785e6683c54.png)
Sarepta Therapeutics Inc
3.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/8279/e9d6e61bb53cd0978278d998b8bcca7b192190c6.png)
Myriad Genetics, Inc.
3.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1669/2672295d4de9d4c74a13d599560ebda2a706ee58.png)
Agilent Technologies Inc.
3.6%
Legend Biotech Corp
3.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/2325/358a25f6ec83a7e5fbe731188b32f51c4ddccb79.png)
Biomarin Pharmaceutical Inc.
3.5%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/8397/21bf6ae443f174645f6ef737d41c782a4be5fa4f.png)
Rocket Pharmaceuticals Inc
3.5%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1673/e570a1d9a905ec6a5917e83176ee8a3abf1bb1c2.png)
Illumina Inc
3.4%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7451/d3c407b87511c7bb3b6c7b8b3213db99bfe66133.png)
Ultragenyx Pharmaceutical Inc.
3.4%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7781/81d528a6daf257a3ca02b92d3aebe8f4197f9a02.png)
Beam Therapeutics Inc
3.2%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7737/a9d98770bb6a542d470d9363991eea2871688f48.png)
Veracyte Inc
2.9%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/2333/0d449023c7976baf1479511dbea3d03150e96a45.png)
10x Genomics Inc
2.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/3431/6c01f9f42fbfecc0e69ac7e26ea4145563f39b38.png)
Genscript Biotech Corporation
2.4%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1649/fdca1ade0333b26298bd832c6770ccd24ce81586.png)
Vertex Pharmaceuticals, Inc.
2.3%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1587/a4bf0354654e79ee5d374bc21eaf6e7f4434b824.png)
Gilead Sciences, Inc.
1.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7847/70468d078f4f3b7fde2ed73b377e026cb33d3efc.png)
Vir Biotechnology Inc
1.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/15351/169dc1693b5285c535dcc1c0506ec448c99f5752.png)
Sana Biotechnology Inc
1.4%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7731/b803f485d95574e32f3fd5479803917dbb40f743.png)
Caredx Inc
1.3%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/8715/79a3aa8179b93bfe2b3b4bd772e2a5bf8f964557.png)
Regenxbio Inc
1.0%
Pacific Biosciences of California Inc
0.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/8045/dbb3525a3cdeba826ea6bb9ebd921ae64119b77a.png)
Editas Medicine Inc
0.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/8735/c0cf543d612da13e35d9659749685fe1cc169b4f.png)
Fulgent Genetics Inc
0.7%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7305/d0adb8e80ef28560a2afed293442ffb8301b053e.png)
Takara Bio Inc.
0.6%
Verve Therapeutics Inc
0.6%
Lyell Immunopharma Inc
0.5%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/8407/cfa7d1cc6d78bae8ba02d7b7906b41a4e9117f59.png)
Allogene Therapeutics Inc
0.5%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/10901/60025349ad412358a64c67d95c7dd6ed58f084c5.png)
uniQure N.V.
0.4%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/10329/0f0be2c241092fff8e07aa24b94fa4c5041d0f04.png)
Poseida Therapeutics Inc
0.4%
2seventy bio Inc
0.4%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/10903/1696972c0af781d5840d441976f0965e6686bbf2.png)
Bluebird bio Inc
0.3%
Caribou Biosciences Inc
0.3%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/247/a8f442e01cd155c054c8da0723aff9dc140f28c5.png)
Eni Spa
< 0.1%
Others
0.1%
No holdings found.
Please try a different search.
Please try a different search.
North America
78.1%
Europe ex‑UK
8.8%
Japan
0.6%
Rest of the World
12.5%
Healthcare
46.4%
Technology
21.5%
Industrial
17.8%
Consumer
< 0.1%
Sector ‐ Other
14.3%
Why InvestEngine
Unbeatable value
From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it
Here's how we're able to do it
Choice of 660+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range
View our ETF range
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.